Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Envoy Medical (COCH) Cost of Revenue (2022 - 2025)

Envoy Medical's Cost of Revenue history spans 4 years, with the latest figure at $405000.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 116.58% year-over-year to $405000.0; the TTM value through Sep 2025 reached $1.2 million, down 30.19%, while the annual FY2023 figure was $1.7 million, 234.54% up from the prior year.
  • Cost of Revenue for Q3 2025 was $405000.0 at Envoy Medical, up from $234000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.1 million in Q4 2023 and bottomed at -$34000.0 in Q2 2023.
  • The 4-year median for Cost of Revenue is $211500.0 (2023), against an average of $289666.7.
  • The largest YoY upside for Cost of Revenue was 820.59% in 2024 against a maximum downside of 58.76% in 2024.
  • A 4-year view of Cost of Revenue shows it stood at $151000.0 in 2022, then soared by 635.76% to $1.1 million in 2023, then tumbled by 83.17% to $187000.0 in 2024, then soared by 116.58% to $405000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Cost of Revenue are $405000.0 (Q3 2025), $234000.0 (Q2 2025), and $358000.0 (Q1 2025).